Amneal Pharmaceuticals, Inc.
NYSE:AMRX
7.21 (USD) • At close June 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 110.552 | 91.542 | 25.976 | 247.79 | 341.378 | 151.197 | 213.394 | 74.166 | 27.367 | 61.087 |
| Short Term Investments
| 0 | 2.2 | 1.821 | 1.174 | 1.696 | 1.123 | 2.142 | 1.851 | 4.354 | 4.977 |
| Cash and Short Term Investments
| 110.552 | 93.742 | 27.797 | 248.964 | 341.378 | 151.197 | 213.394 | 74.166 | 31.721 | 66.064 |
| Net Receivables
| 775.731 | 645.66 | 796.91 | 694.74 | 638.995 | 635.893 | 565.322 | 351.367 | 394.786 | 273.832 |
| Inventory
| 612.454 | 581.384 | 530.735 | 489.389 | 490.649 | 381.067 | 457.219 | 284.038 | 266.161 | 234.965 |
| Other Current Assets
| 56.236 | 91.205 | 113.316 | 88.189 | 45.298 | 73.556 | 98.143 | 62.362 | 33.446 | 29.741 |
| Total Current Assets
| 1,587.806 | 1,377.863 | 1,411.818 | 1,520.108 | 1,551.539 | 1,210.21 | 1,286.644 | 771.933 | 726.114 | 604.602 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 523.693 | 550.137 | 589.36 | 639.003 | 604.71 | 609.153 | 544.146 | 486.758 | 407.404 | 318.822 |
| Goodwill
| 597.436 | 598.629 | 598.853 | 593.017 | 522.814 | 419.504 | 426.226 | 26.444 | 28.441 | 29.824 |
| Intangible Assets
| 732.377 | 890.423 | 1,096.093 | 1,166.922 | 1,304.626 | 1,382.753 | 1,654.969 | 44.599 | 45.929 | 49.691 |
| Goodwill and Intangible Assets
| 1,329.813 | 1,489.052 | 1,694.946 | 1,759.939 | 1,827.44 | 1,802.257 | 2,081.195 | 71.043 | 74.37 | 79.515 |
| Long Term Investments
| 0 | 37.089 | 85.586 | 0 | 0 | 16.373 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | -16.373 | 373.159 | 0.898 | 0 | 0 |
| Other Non-Current Assets
| 60.133 | 18.428 | 17.631 | 20.614 | 22.344 | 44.27 | 67.592 | 11.257 | -481.774 | -398.337 |
| Total Non-Current Assets
| 1,913.639 | 2,094.706 | 2,387.523 | 2,419.556 | 2,454.494 | 2,455.68 | 3,066.092 | 569.956 | 481.774 | 398.337 |
| Total Assets
| 3,501.445 | 3,472.569 | 3,799.341 | 3,939.664 | 4,006.033 | 3,665.89 | 4,352.736 | 1,341.889 | 1,218.817 | 1,014.093 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 258.691 | 143.572 | 166.843 | 131.084 | 153.14 | 103.021 | 114.846 | 70.013 | 60.033 | 69.929 |
| Short Term Debt
| 340.255 | 227.624 | 104.639 | 46.037 | 57.474 | 36.954 | 21.715 | 89.482 | 36.985 | 59.686 |
| Tax Payables
| 0 | 0 | 0.359 | 2.523 | 5.538 | 8.729 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 17.429 | 137.077 | 0 | 0 |
| Other Current Liabilities
| 546.867 | 475.399 | 480.959 | 497.599 | 460.75 | 401.702 | 417.289 | 137.388 | 128.055 | 109.533 |
| Total Current Liabilities
| 1,129.771 | 846.595 | 752.8 | 677.243 | 676.902 | 550.406 | 553.85 | 296.883 | 225.073 | 239.148 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 2,252.884 | 2,522.899 | 2,740.496 | 2,830.019 | 2,887.446 | 2,732.982 | 2,669.681 | 1,395.261 | 1,160.487 | 952.633 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.043 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 1.178 | 2.491 | 0 | 0 |
| Other Non-Current Liabilities
| 228.302 | 83.064 | 122.066 | 65.429 | 96.753 | 35.714 | 231.664 | 10.284 | -0.921 | -1.012 |
| Total Non-Current Liabilities
| 2,481.186 | 2,605.963 | 2,837.613 | 2,895.448 | 2,984.199 | 2,768.696 | 2,902.523 | 1,420.588 | 1,159.566 | 951.621 |
| Total Liabilities
| 3,610.957 | 3,452.558 | 3,590.413 | 3,572.691 | 3,661.101 | 3,319.102 | 3,456.373 | 1,717.471 | 1,394.762 | 1,200.966 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 391.613 | 380.069 | 0 | 0 |
| Common Stock
| 3.099 | 3.066 | 3.036 | 3.014 | 2.997 | 2.992 | 2.987 | 2.716 | 2.675 | 2.675 |
| Retained Earnings
| -607.062 | -490.176 | -406.183 | -276.197 | -286.821 | -377.88 | -20.92 | -382.785 | -175.168 | -181.974 |
| Accumulated Other Comprehensive Income/Loss
| -65.51 | -32.349 | 9.939 | -24.827 | -41.318 | -0.068 | -7.755 | -14.232 | 0 | 0 |
| Other Total Stockholders Equity
| 560.206 | 539.24 | 691.629 | 658.35 | 670.074 | 606.966 | 530.438 | 11.278 | -12.797 | -15.844 |
| Total Shareholders Equity
| -109.267 | 19.781 | 298.421 | 360.34 | 344.932 | 346.788 | 896.363 | -385.739 | -185.29 | -195.143 |
| Total Equity
| -109.512 | 20.011 | 208.928 | 366.973 | 344.932 | 461.566 | 1,287.976 | -375.582 | -175.945 | -186.873 |
| Total Liabilities & Shareholders Equity
| 3,501.445 | 3,472.569 | 3,799.341 | 3,939.664 | 4,006.033 | 3,665.89 | 4,352.736 | 1,341.889 | 0 | 0 |